Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-27

FDA Approved: LEVETIRACETAM — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved an original Abbreviated New Drug Application (ANDA) for Levetiracetam from ScieGen Pharmaceuticals, establishing a generic version of the antis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)